AzTrials
AzTrials

Suicidal ThoughtsNCT07402265

Piloting a Brief, Online Intervention for Suicidality in Sexual and Gender Minority Youth

A study testing KindMind in people with Suicidal Thoughts and Sexual and Gender Minorities, run by Western University at 1 site in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Sexual and gender minority youth (i.e., LGBTQ+ individuals) are at elevated risk for suicidal thoughts compared to cisgender/heterosexual youth and there is increased demand for programs and treatments tailored to this population. Read more about this study

Who is it for?
Ages 13 to 25 years
What is being tested?
KindMind
Could I receive a placebo?
No, everyone receives an active treatment
How many people
250 participants
Where
1 siteCanada
Study dates
1 Feb 2026to 30 Sep 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 25 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Resident of Canada
  • Fluent in English
  • Youth (i.e., 13-25 years)
  • Identifies as a sexual and/or gender minority (i.e., any sexual identity excluding heterosexual and/or any gender identity excluding cisgender)
  • Endorses experiencing any suicidal ideation within the past 6 months
  • Access to a computer and able to participate virtually

Who cannot join

  • Does not meet the inclusion criteria

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Genevieve M Bianchini, MSc contact

519-661-2111 ext. 87316

gbianch2@uwo.ca

Canada1 site, 1 recruiting
  • Western University

    London, Ontario

    Lindsay Bodell, PhD, 519-661-2111 ext. x80486, lbodell@uwo.ca

    Lindsay Bodell, PhD

    Recruiting

Other trials in Canada

About this study

Sexual and gender minority youth (i.e., LGBTQ+ individuals) are at elevated risk for suicidal thoughts compared to cisgender/heterosexual youth and there is increased demand for programs and treatments tailored to this population. The current study seeks to pilot a brief, online, self-guided intervention for suicidal thoughts designed for sexual and gender minority youth to test if this intervention is acceptable to this population and if completing this intervention significantly decreases suicidal thoughts.

Read the detailed description

The current study will pilot an intervention for suicidal thoughts in sexual and gender minority youth. We will recruit of a sample of sexual and gender minority youth who report experiencing recent thoughts of suicide. Participants will be asked to complete a battery of questionnaires including demographic questions and mental health symptom assessments, then complete the intervention, and finally complete additional questionnaires. One month after completing the intervention, participants will be asked to complete a series of questionnaires. This study is designed to evaluate the acceptability and initial effectiveness of this intervention and will not include a control group.

Being tested
KindMind
Keywords
Suicidal thoughts, Sexual and Gender Minorities, Youth, Brief, Online, Self-Guided, Self-Compassion, Self-Neutrality
Medical subject headings
Suicidal Ideation, Coitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • KindMindBehavioural

    This intervention is hosted on Wix-com and involves multiple self-guided modules in which participants are taught how to use self-compassion and/or self-neutrality to reduce suicidal thoughts. This intervention is tailored to sexual and gender minority youth.

Study groups in NCT07402265
Study groupRoleWhat they receive
Intervention GroupExperimentalParticipants will complete the online, self-guided program, which will take approximately 30 minutes and involve participants completing modules describing how to use self-compassion/self-neutrality techniques to reduce suicidal thoughts.
Receives: Behavioral: KindMind

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Suicidal Ideation Questionnaire - Junior

    Suicidal Ideation Questionnaire - Junior (SIQ-Jr; Reynolds, 1987). The SIQ-Jr was used to assess suicidal ideation in the current study. This self-report measure include 15 items of suicidal thoughts that are rated on a 7-item scale (i.e., Almost every day, couple of times a week, about once a week, couple of times a month, About once a month, I had this thought before but not in the past month, I never had this thought) of how frequency the respondent had each thought in their mind over the past month. Sample items include I thought about dying, I wished I were dead, and I thought about killing myself. The SIQ-Jr is scored by summing the responses to create a total score from 0-90, with higher scores indicating a higher severity of suicidal ideation.

    Measured: From Baseline (i.e., before intervention administration) to four weeks after intervention administration.

Secondary outcomes (6)
  1. Suicidal Ideation Thoughts and Behaviours Interview - Revised

    Suicidal Ideation Thoughts and Behaviours Interview - Revised (SITBI -R; Gratch et al., 2022). Select items from the SITBI-R will be administered to capture suicidal behaviour, including frequency and severity of suicide attempts.

    Measured: From Baseline (i.e., before intervention administration) to four weeks after intervention administration.

  2. Self-Compassion Scale - Short Form

    Self-Compassion Scale - Short Form (SCS-SF; Raes et al., 2011). The SCS-SF is a 12-item measure that assesses trait self-compassion. Each item is rated on a 5-point scale of how the participant typically reacts to themselves during difficult times, ranging from Almost never to Almost Always. Six subscales are computed corresponding to the six components of self-compassion based on Neff's (2003) conceptualization: Self-Kindness, Self-Judgement, Common Humanity, Isolation, Mindfulness, and Overidentification. A total score is computed by averaging the six subscale total scores. Higher scores indicated higher self-compassion. Sample items include I try to see my failing as part of the human condition and I'm disapproving and judgmental about my own flaws and inadequacies.

    Measured: From Baseline (i.e., before intervention administration) to four weeks after intervention administration.

  3. Patient Health Questionnaire - 9

    Patient Health Questionnaire - 9 (PHQ-9; Kroenke et al., 2001). The PHQ-9 a self-report assessment of depressive symptoms. The PHQ-9 includes nine items that ask participants to rate how frequently they experienced each problem (i.e., Little interest or pleasure in doing things, Feeling tired or having low energy) over the past two weeks, with a 4-point scale of frequency (i.e., Not at all, Several days, More than half the days, Nearly every day). A total score is summed and can range from 0-27. Higher total scores indicate greater severity of depressive symptoms. An additional item not included in the total score asks participants to rate how difficult the problems they indicated make it for them to do work, take care of things at home, and get along with other people.

    Measured: From Baseline (i.e., before intervention administration) to four weeks after intervention administration.

  4. Hopelessness Scale for Children

    Hopelessness Scale for Children (HSC; Kazdin et al., 1983). The HSC includes 17 true/false items assessing hopelessness in children as young as 5 years old. Total scores are summed and the higher the total score, the greater the hopelessness for the future. Sample items include I will have more good times than bad times and I don't think I will get what I really want.

    Measured: From Baseline (i.e., before intervention administration) to four weeks after intervention administration.

  5. Generalized Anxiety Disorder - 7

    Generalized Anxiety Disorder - 7 (GAD-7; Spitzer et al., 2006) . The GAD-7 is a self-report assessment of anxiety. The respondent indicates how often they have experienced each of seven listed symptoms over the past two weeks, including items such as Not being able to stop or control worrying and Becoming easily annoyed or irritable. Items are rated on a 4-point scale of frequency (i.e., Not at all, Several days, More than half the days, Nearly every day). Total scores range from 0-21, with higher scores indicating higher severity of anxiety. An additional item not included in the total score asks participants to rate how difficult the problems they indicated make it for them to do work, take care of things at home, and get along with other people.

    Measured: From Baseline (i.e., before intervention administration) to four weeks after intervention administration.

  6. Difficulties in Emotion Regulation Scale - Short Form

    Difficulties in Emotion Regulation Scale - Short Form (DERS-SF; Kaufman et al., 2016). The DERS-SF is a self-report measure of difficulties regulating emotion. This measure has 18 items that are rated on a 5-point scale assessing how often each item applies to the participant, including the following options: Almost never (0-10%), Sometimes (11-35%), About half of the time (36-65%, Most of the time (66-90%), and Almost always (91-100%). The DERS-SF includes items such as When I'm upset, I have difficulty concentrating and I pay attention to how I feel. A total score and six subscale scores (Strategies, Nonacceptance, Impulse, Goals, Awareness, Clarity) are created by adding item scores and higher scores reflect greater difficulties with emotion regulation. Total scores range from 18-90.

    Measured: From Baseline (i.e., before intervention administration) to four weeks after intervention administration.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2026
  2. Study start1 Feb 2026
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion30 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
All participants will complete the same program. There is no control group.
Masking
None (open label)
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07402265
Sponsor's protocol ID
127209
Status last verified
Feb 2026
First submitted
30 Jan 2026
Last updated
21 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Only de-identified IPD that is included in the published results of the study will be shared.

Questions about this trial

What is this clinical trial studying?

A study testing KindMind in people with Suicidal Thoughts and Sexual and Gender Minorities, run by Western University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Genevieve M Bianchini, MSc (519-661-2111 ext. 87316, gbianch2@uwo.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Suicidal Ideation Questionnaire - Junior (time frame: From Baseline (i.e., before intervention administration) to four weeks after intervention administration.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in